Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Multisite external validation of blood test for colorectal neoplasia screening in a majority average-risk screening cohort of 449 subjects.
Authors
Shai Friedland
Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA
Shai Friedland , Drew Watson , Douglas K. Rex , Ashish Nimgaonkar , Zhen Zhang , Alex Atkins , Ben Hsieh , Jr-Ming Lai , Stephen Su , Jen-chia Wu , Hung-Jen Shao , Jessica Tesoriero , Lindsey Hannah , John McGowan , Daniel S Mishkin , Ekta Gupta , Samir Gupta , John J. Sninsky , Rui Mei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
NCT05127096
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 66)
DOI
10.1200/JCO.2024.42.3_suppl.66
Abstract #
66
Poster Bd #
E9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Assessment of price variation in colorectal cancer screening procedures at US hospitals.
First Author: Ishan Paranjpe
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants.
First Author: Shai Friedland
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment.
First Author: Sebastian Heidenreich
Poster
2024 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): Acceptance, knowledge, and preferences in Brazil.
First Author: Victor Filogonio